Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 92

1.

Tumor volume discrepancies between FDG-PET and MRI for cervical cancer.

Ma DJ, Zhu JM, Grigsby PW.

Radiother Oncol. 2011 Jan;98(1):139-42. doi: 10.1016/j.radonc.2010.10.004.

PMID:
20971521
[PubMed - indexed for MEDLINE]
2.

Prognostic value of metabolic tumor volume measured by FDG-PET/CT in patients with cervical cancer.

Chung HH, Kim JW, Han KH, Eo JS, Kang KW, Park NH, Song YS, Chung JK, Kang SB.

Gynecol Oncol. 2011 Feb;120(2):270-4. doi: 10.1016/j.ygyno.2010.11.002. Epub 2010 Nov 24.

PMID:
21109300
[PubMed - indexed for MEDLINE]
3.

Positron emission tomography for radiation treatment planning.

Grosu AL, Piert M, Weber WA, Jeremic B, Picchio M, Schratzenstaller U, Zimmermann FB, Schwaiger M, Molls M.

Strahlenther Onkol. 2005 Aug;181(8):483-99. Review.

PMID:
16044216
[PubMed - indexed for MEDLINE]
4.

FDG-PET in the detection of recurrence of uterine cervical carcinoma following radiation therapy--tumor volume and FDG uptake value.

Sakurai H, Suzuki Y, Nonaka T, Ishikawa H, Shioya M, Kiyohara H, Katoh H, Nakayama Y, Hasegawa M, Nakano T.

Gynecol Oncol. 2006 Mar;100(3):601-7. Epub 2005 Oct 28.

PMID:
16257440
[PubMed - indexed for MEDLINE]
5.

18F-fluorodeoxyglucose-positron emission tomography and pathologic tumor size in early-stage invasive cervical cancer.

Showalter TN, Miller TR, Huettner P, Rader J, Grigsby PW.

Int J Gynecol Cancer. 2009 Nov;19(8):1412-4. doi: 10.1111/IGC.0b013e3181b62e8c.

PMID:
20009899
[PubMed - indexed for MEDLINE]
6.

Correlation of apparent diffusion coefficients measured by 3T diffusion-weighted MRI and SUV from FDG PET/CT in primary cervical cancer.

Ho KC, Lin G, Wang JJ, Lai CH, Chang CJ, Yen TC.

Eur J Nucl Med Mol Imaging. 2009 Feb;36(2):200-8. doi: 10.1007/s00259-008-0936-5. Epub 2008 Sep 9.

PMID:
18779960
[PubMed - indexed for MEDLINE]
7.

Detection of hematogenous bone metastasis in cervical cancer: 18F-fluorodeoxyglucose-positron emission tomography versus computed tomography and magnetic resonance imaging.

Liu FY, Yen TC, Chen MY, Lai CH, Chang TC, Chou HH, Hong JH, Chen YR, Ng KK.

Cancer. 2009 Dec 1;115(23):5470-80. doi: 10.1002/cncr.24599.

PMID:
19739235
[PubMed - indexed for MEDLINE]
Free Article
8.

18F-Fluorodeoxyglucose-PET/CT to evaluate tumor, nodal disease, and gross tumor volume of oropharyngeal and oral cavity cancer: comparison with MR imaging and validation with surgical specimen.

Seitz O, Chambron-Pinho N, Middendorp M, Sader R, Mack M, Vogl TJ, Bisdas S.

Neuroradiology. 2009 Oct;51(10):677-86. doi: 10.1007/s00234-009-0586-8.

PMID:
19727695
[PubMed - indexed for MEDLINE]
9.

Comparison of five segmentation tools for 18F-fluoro-deoxy-glucose-positron emission tomography-based target volume definition in head and neck cancer.

Schinagl DA, Vogel WV, Hoffmann AL, van Dalen JA, Oyen WJ, Kaanders JH.

Int J Radiat Oncol Biol Phys. 2007 Nov 15;69(4):1282-9.

PMID:
17967318
[PubMed - indexed for MEDLINE]
10.

Comparative benefits and limitations of 18F-FDG PET and CT-MRI in documented or suspected recurrent cervical cancer.

Yen TC, Lai CH, Ma SY, Huang KG, Huang HJ, Hong JH, Hsueh S, Lin WJ, Ng KK, Chang TC.

Eur J Nucl Med Mol Imaging. 2006 Dec;33(12):1399-407. Epub 2006 Jul 18.

PMID:
16847653
[PubMed - indexed for MEDLINE]
11.

A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.

Kauhanen SP, Komar G, Seppänen MP, Dean KI, Minn HR, Kajander SA, Rinta-Kiikka I, Alanen K, Borra RJ, Puolakkainen PA, Nuutila P, Ovaska JT.

Ann Surg. 2009 Dec;250(6):957-63. doi: 10.1097/SLA.0b013e3181b2fafa.

PMID:
19687736
[PubMed - indexed for MEDLINE]
12.

FDG PET-CT in cervical cancer: relationship between primary tumor FDG uptake and metastatic potential.

Yilmaz M, Adli M, Celen Z, Zincirkeser S, Dirier A.

Nucl Med Commun. 2010 Jun;31(6):526-31. doi: 10.1097/MNM.0b013e32833800e7.

PMID:
20215979
[PubMed - indexed for MEDLINE]
13.

Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer.

Deniaud-Alexandre E, Touboul E, Lerouge D, Grahek D, Foulquier JN, Petegnief Y, Grès B, El Balaa H, Keraudy K, Kerrou K, Montravers F, Milleron B, Lebeau B, Talbot JN.

Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1432-41. Epub 2005 Aug 25.

PMID:
16125870
[PubMed - indexed for MEDLINE]
14.

Diagnostic performance of fluorodeoxyglucose positron emission tomography/magnetic resonance imaging fusion images of gynecological malignant tumors: comparison with positron emission tomography/computed tomography.

Nakajo K, Tatsumi M, Inoue A, Isohashi K, Higuchi I, Kato H, Imaizumi M, Enomoto T, Shimosegawa E, Kimura T, Hatazawa J.

Jpn J Radiol. 2010 Feb;28(2):95-100. doi: 10.1007/s11604-009-0387-3. Epub 2010 Feb 26.

PMID:
20182843
[PubMed - indexed for MEDLINE]
15.
16.

Positron emission tomography in evaluating the feasibility of curative intent in cervical cancer patients with limited distant lymph node metastases.

Chao A, Ho KC, Wang CC, Cheng HH, Lin G, Yen TC, Lai CH.

Gynecol Oncol. 2008 Aug;110(2):172-8. doi: 10.1016/j.ygyno.2008.03.018. Epub 2008 May 22.

PMID:
18499238
[PubMed - indexed for MEDLINE]
17.

Biological image-guided radiotherapy in rectal cancer: challenges and pitfalls.

Roels S, Slagmolen P, Nuyts J, Lee JA, Loeckx D, Maes F, Vandecaveye V, Stroobants S, Ectors N, Penninckx F, Haustermans K.

Int J Radiat Oncol Biol Phys. 2009 Nov 1;75(3):782-90. doi: 10.1016/j.ijrobp.2008.11.031. Epub 2009 Mar 14.

PMID:
19289265
[PubMed - indexed for MEDLINE]
18.
19.

Relation between FIGO stage, primary tumor volume, and presence of lymph node metastases in cervical cancer patients referred for radiotherapy.

Narayan K, McKenzie AF, Hicks RJ, Fisher R, Bernshaw D, Bau S.

Int J Gynecol Cancer. 2003 Sep-Oct;13(5):657-63.

PMID:
14675351
[PubMed - indexed for MEDLINE]
20.

Preliminary report of using FDG-PET to detect extrapelvic lesions in cervical cancer patients with enlarged pelvic lymph nodes on MRI/CT.

Tsai CS, Chang TC, Lai CH, Tsai CC, Ng KK, Hsueh S, Yen TC, Hong JH.

Int J Radiat Oncol Biol Phys. 2004 Apr 1;58(5):1506-12.

PMID:
15050330
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk